Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma-Reference-Cited by-同舟云学术

Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma

Published:2021-06 Issue: Volume:150 Page:130-132
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Boutros Celine,Rouleau Etienne,Majer Michael,Nikolaev Sergei,Robert Caroline

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference9 articles.

1. Xeroderma pigmentosum;Lehmann;Orphanet J Rare Dis,2011

2. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: case report and review of the literature;Deinlein;Eur J Canc,2017

3. Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab;Hauschild;Eur J Canc,2017

4. Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease;Momen;Cold Spring Harb Mol Case Stud,2019

5. Angiosarcoma arising on the scalp in a Korean patient with xeroderma pigmentosum variant type;Hong;Photodermatol Photoimmunol Photomed,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers;Frontiers in Oncology;2023-10-25

2. The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies;Cancers;2023-05-10